Scotoma Awareness Training for Low Vision
(SPOT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores new methods to improve vision for individuals with severe vision impairment, particularly those with macular degeneration. The researchers aim to understand how the brain adapts after losing central vision and to discover new therapies for low vision. Participants will engage in various training methods, including Scotoma Perimetry Oculomotor Training (a type of eye movement training), to determine which method enhances their ability to recognize visual cues. Individuals with severe vision loss in both eyes due to macular degeneration for at least two years may be suitable candidates. As an unphased trial, this study provides a unique opportunity to contribute to groundbreaking research that could lead to new therapies for vision impairment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this training is safe for individuals with low vision?
Research has shown that Scotoma Perimetry Oculomotor Training could benefit individuals with vision loss due to central scotomas. In one study with six participants, 83% improved their ability to focus on words for reading after the training. This suggests the treatment is generally well-received and may assist with vision-related tasks.
This treatment is neither a medication nor surgery, which usually means fewer risks of side effects. It involves visual training that enhances coordination between the brain and eyes. Being non-invasive, it typically presents few safety concerns. However, as with any new treatment, discussing potential risks with the trial team and healthcare providers is important.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores innovative ways to help individuals with low vision become more aware of their scotomas, or blind spots. Unlike standard vision therapy that might focus on enhancing overall visual acuity, this trial uses a unique "scotoma awareness" training method where participants identify emotions on an emoji face, with a visible outline of their scotoma rendered on screen. This gaze-contingent display adapts to the participant's performance, making it a tailored approach to improving visual awareness. The hope is that by training people to recognize and adapt to their blind spots, they can experience better functional vision in daily life.
What evidence suggests that this trial's treatments could be effective for low vision?
Research has shown that Scotoma Perimetry Oculomotor Training, which participants in this trial may receive, can be a promising method for people with central vision loss. In one study with patients who had severe vision loss due to central blind spots, 83% found a new way of seeing that improved their reading ability. This was achieved by creating a new focus point on the retina, called a preferred retinal locus (PRL), which helps bypass the blind spot. Eccentric viewing training, a similar technique, is part of the control training in this trial and has also proven effective for improving low vision. These findings suggest that specific visual training can greatly enhance vision tasks for those with central vision problems.12367
Are You a Good Fit for This Trial?
This trial is for adults with severe vision impairment (20/100 or worse) due to Macular Degeneration. Participants must have had this level of vision loss for at least two years and show specific light sensitivity differences between their macula and peripheral retina. Those who can't remain still during eye tracking or have very large retinal blind spots are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Training
Participants undergo 'scotoma awareness' training with a simulated scotoma to promote PRL development
Follow-up
Participants are monitored for changes in visual abilities and oculomotor strategies after training
What Are the Treatments Tested in This Trial?
Interventions
- Control Training
- Scotoma Perimetry Oculomotor Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of California, Riverside
Collaborator